Internal Medicine, Pulmonary Disease · Topeka, KS
NPI
1730393000
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
823 SW Mulvane St Ste 380
Topeka, KS, 66606
Phone (785) 354-9591
Groups this clinician bills Medicare through
Medicare paid, 2024
$255K
2,834 services
Medicare patients, 2024
1,072
Average age 74
Drug cost, 2024
$1.4M
2,044 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vlad Dimitriu was code 99291 (critical care e&m), 803 times for 328 patients. In total Vlad Dimitriu billed 2,834 services in 51 codes, and Medicare paid $255K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99291 Critical Care E&M | Facility | 803 | 328 | $147.69 | $119K |
| 99233 Hospital E&M - Subsequent | Facility | 247 | 136 | $86.74 | $21K |
| 99214 Office E&M - Established | Office | 190 | 174 | $86.14 | $16K |
| 99215 Office E&M - Established | Office | 188 | 142 | $130.03 | $24K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 122 | 107 | $12.11 | $1,477 |
| 99232 Hospital E&M - Subsequent | Facility | 116 | 70 | $57.91 | $6,717 |
| 99223 Hospital E&M - Initial | Facility | 109 | 104 | $125.10 | $14K |
| 94729 Pulmonary Function Testing | Office | 106 | 63 | $21.82 | $2,313 |
| 94726 Pulmonary Function Testing | Office | 106 | 63 | $21.36 | $2,265 |
| 95811 Sleep Study | Facility | 83 | 83 | $76.77 | $6,372 |
| 94010 Pulmonary Function Testing | Office | 72 | 42 | $10.30 | $742 |
| 95810 Sleep Study | Facility | 56 | 56 | $82.27 | $4,607 |
| 94726 Pulmonary Function Testing | Facility | 52 | 52 | $8.55 | $445 |
| 94729 Pulmonary Function Testing | Facility | 49 | 49 | $6.31 | $309 |
| 99205 Office E&M - New | Office | 44 | 44 | $149.95 | $6,598 |
By year: 2022 $278K for 2,787 services; 2023 $245K for 2,619 services; 2024 $255K for 2,834 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 23 | 15 | $8.65 | $199 |
Medicare prescription drug claims, 2024
In 2024, the drug Vlad Dimitriu prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 488 prescriptions and refills. In total Vlad Dimitriu wrote 2,044 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 488 | 530 | 67 | $331K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 177 | 189 | 55 | $4,880 |
| Montelukast Sodium Generic | 139 | 261 | 31 | $1,996 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 109 | 131 | 22 | $60K |
| Azithromycin Generic | 96 | 182 | 35 | $1,107 |
| Breo Ellipta Fluticasone/Vilanterol | 87 | 107 | 16 | $41K |
| Prednisone Generic | 59 | 101 | 35 | $212 |
| Ventolin Hfa Albuterol Sulfate | 46 | 46 | Under 11 | $2,563 |
| Fluticasone Propionate Generic | 42 | 93 | 17 | $508 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 41 | 49 | 11 | $7,243 |
| Advair Hfa Fluticasone Propion/Salmeterol | 41 | 49 | Under 11 | $18K |
| Incruse Ellipta Umeclidinium Bromide | 38 | 48 | Under 11 | $17K |
| Ipratropium Bromide Generic | 33 | 37 | Under 11 | $902 |
| Spiriva Handihaler Tiotropium Bromide | 31 | 63 | Under 11 | $31K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 31 | 37 | Under 11 | $17K |
Brand drugs: 1,250 claims; generic drugs: 794 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Vlad Dimitriu were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.